Locab Tablet 60/5 mg
Fimasartan Potassium Trihydrate Granules 150mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Boryung Biopharma Co., Ltd.
MFDS item code 201700492 · Approved 2017.01.25
Treatment of hypertension and dyslipidemia, inhibition of atherosclerosis progression, prevention of cardiovascular disease
This medication is used for patients receiving both Pimasartan for hypertension treatment and Rosuvastatin calcium for hyperlipidemia treatment. Pimasartan helps control essential hypertension. Rosuvastatin calcium is used for treating hypercholesterolemia and various types of dyslipidemia, especially when dietary control is insufficient. It also contributes to reducing the risk of cardiovascular disease, as well as the recurrence of stroke and myocardial infarction after arterial revascularization. By administering these two medications together, hypertension and hyperlipidemia can be effectively managed, thereby improving cardiovascular health.
This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, fimasartan/rosuvastatin. ○ Fimasartan 1. Adults The recommended dose is 30~60 milligrams once daily, administered regardless of food. If blood pressure is not adequately controlled at this dose, it may be increased to 120 milligrams once daily. If possible, it is recommended to take the medicine at the same time each day (e.g., in the morning). The antihypertensive effect appears within 2 weeks after starting treatment and reaches its maximum effect after approximately 8 weeks~12 weeks. 2. Older adults No initial dosage adjustment is required for older adults up to 70 years of age. (See section 9, Administration to Older Adults, under Precautions for Use.) 3. Patients with renal impairment No dosage adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30~80 mL/min). In patients with severe renal impairment (creatinine clearance < 30 mL/min), initiate treatment at 30 milligrams once daily and do not exceed 60 milligrams daily. 4. Patients with hepatic impairment No dosage adjustment is required in patients with mild hepatic impairment. Do not administer this medicine to patients with moderate to severe hepatic impairment (see section 2, Patients in Whom the Medicine Must Not Be Administered, and section 10, Administration to Patients with Hepatic Impairment, under Precautions for Use). 5. Patients with reduced effective circulating blood volume (e.g., patients taking high doses of diuretics) For patients at high risk of hypotension, such as those with reduced effective circulating blood volume, an initial dose of 30 milligrams once daily is recommended. (See section 3, Administration with Caution, under Precautions for Use.) ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is required, adjust the dose to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. Adjust the maintenance dose as appropriate at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and patient response; it may be increased to a maximum of 20 milligrams daily. 2. Older adults No dosage adjustment is required. 3. Patients with renal failure No dosage adjustment is required in patients with mild or moderate renal failure. Do not administer to patients with severe renal failure. Use particular caution when administering 20mg of this medicine to patients with moderate renal failure. 4. Patients with hepatic failure No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 5. Race Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients. Patients taking fimasartan and rosuvastatin concomitantly may switch to this medicine (a fixed-dose combination containing the same amounts of each active ingredient) for convenience.
This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. Patients with allergies to the ingredients of this medication, pregnant or breastfeeding women, and fertile women not using appropriate contraception should not take this medication. Patients with severely impaired liver function or significantly reduced kidney function, and those with certain muscle diseases should also avoid using this medication. Patients with insufficient blood volume or salt may experience hypotension, so close monitoring of their condition is necessary when starting treatment or increasing the dosage. Caution is also advised for patients with renal impairment, renovascular hypertension, and cardiac valve disease, and regular liver function tests should be conducted. This medication can affect the liver and muscles, so if symptoms such as muscle pain, fatigue, or fever occur, patients should inform their physician immediately, and blood tests may be required to check for muscle damage. This medication may interact with other drugs; therefore, inform your doctor or pharmacist if you are taking any other medications. Drowsiness and dizziness may occur while taking this medication, hence caution is required when driving or operating dangerous machinery. Women who are pregnant or planning to become pregnant should avoid taking this medication, and breastfeeding women should refrain from its use. This medication is not recommended for children under 18 years of age as safety and effectiveness have not been established. Elderly patients may also be more sensitive to this medication, thus caution is required when taking it. In case of overdose, seek immediate medical attention for appropriate treatment, as there is no specific antidote, and treatment should be based on symptoms. Keep this medication out of the reach of children, and avoid transferring it to another container as this can affect its quality.
Dyspepsia, nausea, fever, hepatitis, headache, dizziness, upper abdominal pain, esophagitis, gastroenteritis, nasopharyngitis, tonsillitis, upper respiratory tract infection, elevated ALT, elevated γ-GTP, elevated liver enzyme levels, increased white blood cell count, urinary disorders, frequent urination, cough, hyperkalemia, arthralgia, insomnia, pruritus, syncope, sedation, migraine, vomiting, weakness, foreign body sensation, reduced platelet count, increased serum creatine phosphokinase, muscle contractions, musculoskeletal stiffness, facial flushing, flushing, erectile dysfunction, angioedema, diabetes, constipation, abdominal pain, pancreatitis, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, jaundice, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, nightmares, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, severe muscle weakness, ocular myasthenia, contusion, epilepsy, amyotrophic lateral sclerosis, neuropathy, neuronitis, facial paralysis, normal pressure hydrocephalus, spinal stenosis, acute pancreatitis, intestinal obstruction, hemorrhagic duodenal ulcer, appendicitis, hemorrhoids, abdominal pain, intracranial hemorrhage, transient ischemic attack, atherosclerosis, worsening cerebral infarction, cerebral hemorrhage, liver cancer, colon carcinoma, neoplasm unspecified, cervical cancer, prostate cancer, acute renal failure, chronic renal failure, kidney stones, pyelonephritis, urinary incontinence, rhinitis, fibrosing alveolitis, pharyngitis, pneumonia, lung disease, death, aggravated low back pain, osteoarthritis, arthropathy, hypoglycemia, pulmonary embolism, purpura, bradycardia, atrial fibrillation, coronary artery disease, aortic stenosis, heart failure, increased blood pressure, acute hepatitis, benign pituitary neoplasm, otitis media, uterine prolapse, recurrent cancer, postoperative pain, chest pain, low back pain, limb pain, facial edema, fatigue, fever, neck/shoulder pain, fracture, pharyngitis, upper respiratory tract infection, sputum, nosebleed, bronchitis, paresthesia, numbness, tremors, hypertonia, anxiety, memory impairment, decreased appetite, gastroesophageal reflux, gastritis, diarrhea, functional gastrointestinal disorders, frequent urination, urinary incontinence, kidney stones, chronic renal failure, dysuria, hyperlipidemia, dyslipidemia, hypoglycemia, increased blood pressure, purpura, fatty liver, localized inflammation, soft tissue inflammation, lymphadenopathy, wounds, septal deviation, heat intolerance, falling, allergy, chills, nasal polyps, edema, peripheral edema, chest discomfort, decreased appetite, abdominal distension, muscle cramps, gout, erectile dysfunction
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It's important to maintain a storage temperature between 1 and 30 degrees Celsius.
Yellow, convex, octagonal film-coated tablets
30 tablets (10 tablets/PTP pack x 3), 100 tablets (10 tablets/PTP pack x 10)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Fimasartan Potassium Trihydrate Granules 150mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Boryung Biopharma Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 150mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Boryung Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 150mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 300mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 75mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 75mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Fimasartan Potassium Trihydrate Granules 75mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Boryung Biopharma Co., Ltd.
Fimasartan Potassium Trihydrate Granules 75mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Boryung Biopharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.